Adult Type Granulosa Cell Tumour in a Peri-Menopausal Woman: A Rare Ovarian Malignancy

被引:0
作者
Kumar, Mansi [1 ]
Kalthe, Bhavika [1 ]
Dhillon, A. S. [1 ]
Kaur, Gagandeep [1 ]
机构
[1] Maharishi Markandeshwar Deemed Be Univ, Dept Obstet & Gynaecol, Ambala, Haryana, India
来源
JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE | 2020年 / 8卷 / 06期
关键词
GCT (Granulosa Cell Tumour); BEP; (bleomycin; etoposide; and cisplatin); PROGNOSTIC FACTORS; MANAGEMENT; CHEMOTHERAPY; DIAGNOSIS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Granulosa cell tumors of the ovary are exceedingly rare neoplasms that originate from sex-cord stromal cells. The long natural history of granulosa cell tumors and their tendency to recur years after the initial diagnosis are the most prominent of their characteristics. The secretion of estradiol is the reason for signs at presentation such as vaginal bleeding and precocious puberty. Abdominal pain and hemoperitoneum, which occasionally can occur, are attributable to tumor rupture. The most common finding in pelvic examination is a tumor mass, which is subsequently confirmed with imaging techniques. Surgery is the mainstay of initial management for histological diagnosis, appropriate staging, and debulking. Chemotherapy is the treatment of choice for patients with advanced, recurrent, or metastatic disease, and BEP is the preferred regimen. Although the overall rate of response to treatment is high, the impact of treatment on disease-free or overall survival is unknown. Prolonged surveillance is mandatory because tumors tend to recur years after the initial diagnosis. Here we present a rare case of Granulosa cell tumour in a perimenopausal woman. Massive ascites as the first sign of ovarian granulosa cell tumor (GCT) in a peri-menopausal female is an extremely rare presentation and its clinical features and treatment methods have not been well described yet.
引用
收藏
页码:200 / 204
页数:5
相关论文
共 33 条
[1]   Fine needle aspiration cytology diagnosis of metastatic adult granulosa cell tumour showing Call-Exner bodies [J].
Ahuja, A. ;
Iyer, V. K. ;
Mathur, S. ;
Vijay, M. K. .
CYTOPATHOLOGY, 2013, 24 (05) :346-347
[2]  
[Anonymous], 1987, NEW ENGL J MED, V316, P650
[3]   PROGNOSTIC FACTORS IN GRANULOSA-CELL TUMORS [J].
BJORKHOLM, E ;
SILFVERSWARD, C .
GYNECOLOGIC ONCOLOGY, 1981, 11 (03) :261-274
[4]   Juvenile granulosa cell tumors of the ovary in children and adolescents: Results from 33 patients registered in a prospective cooperative study [J].
Calaminus, G ;
Wessalowski, R ;
Harms, D ;
Gobel, U .
GYNECOLOGIC ONCOLOGY, 1997, 65 (03) :447-452
[5]   Ovarian sex cord-stromal tumors: An immunohistochemical study including a comparison of calretinin and inhibin [J].
Deavers, MT ;
Malpica, A ;
Liu, JS ;
Broaddus, R ;
Silva, EG .
MODERN PATHOLOGY, 2003, 16 (06) :584-590
[6]  
Elbachiri Meriem, 2017, Pan Afr Med J, V26, P198, DOI 10.11604/pamj.2017.26.198.11523
[7]  
EVANS AT, 1980, OBSTET GYNECOL, V55, P231
[8]  
FOX H, 1975, CANCER, V35, P231, DOI 10.1002/1097-0142(197501)35:1<231::AID-CNCR2820350128>3.0.CO
[9]  
2-O
[10]   Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma [J].
Graziani, Silvia R. ;
Vital, Carolina G. ;
Morikawa, Aleksandra T. ;
Van Eyll, Brigitte M. ;
Fernandes Junior, Hezio J. ;
Kalil Filho, Roberto ;
Maranhao, Raul C. .
MEDICAL ONCOLOGY, 2017, 34 (09)